Tenaya Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Tenaya Therapeutics, Inc. (TNYA) reported Basic Shares Outstanding (Weighted Average) of 217.57 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 217.57M shares, a 33.65% increase year-over-year.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 216.88M shares, a 97.40% increase year-over-year.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 175.29M shares, a 102.84% increase year-over-year.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 163.35M shares, a 89.58% increase year-over-year.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 152.97M shares, a 80.34% increase from fiscal 2024.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 84.82M shares, a 14.96% increase from fiscal 2023.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 73.79M shares, a 64.61% increase from fiscal 2022.
- Tenaya Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 44.82M shares, a 152.75% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 217.57M shares 10-Q · filed 2026-08-05 | 217.23M shares 10-Q · filed 2026-08-05 | 203.25M shares derived: average of 3 quarters · filed 2026-08-05 | 193.27M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 216.88M shares 10-Q · filed 2026-05-06 | 196.09M shares derived: average of 2 quarters · filed 2026-05-06 | 185.17M shares derived: average of 3 quarters · filed 2026-05-06 | 179.58M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 175.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 169.32M shares derived: average of 2 quarters · filed 2026-03-11 | 167.14M shares derived: average of 3 quarters · filed 2026-08-05 | 152.97M shares 10-K · filed 2026-03-11 |
| 2025-09-30 | 163.35M shares 10-Q · filed 2025-11-10 | 163.07M shares derived: average of 2 quarters · filed 2026-08-05 | 145.53M shares 10-Q · filed 2025-11-10 | 130.61M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 162.79M shares 10-Q · filed 2026-08-05 | 136.48M shares 10-Q · filed 2026-08-05 | 119.69M shares derived: average of 3 quarters · filed 2026-08-05 | 111.31M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 109.87M shares 10-Q · filed 2026-05-06 | 98.14M shares derived: average of 2 quarters · filed 2026-05-06 | 94.15M shares derived: average of 3 quarters · filed 2026-05-06 | 92.04M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 86.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 86.29M shares derived: average of 2 quarters · filed 2026-03-11 | 86.10M shares derived: average of 3 quarters · filed 2026-03-11 | 84.82M shares 10-K · filed 2026-03-11 |
| 2024-09-30 | 86.16M shares 10-Q · filed 2025-11-10 | 85.93M shares derived: average of 2 quarters · filed 2025-11-10 | 84.29M shares 10-Q · filed 2025-11-10 | 81.81M shares derived: average of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | 85.71M shares 10-Q · filed 2025-08-06 | 83.34M shares 10-Q · filed 2025-08-06 | 80.37M shares derived: average of 3 quarters · filed 2025-08-06 | 78.76M shares derived: average of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | 80.98M shares 10-Q · filed 2025-05-07 | 77.69M shares derived: average of 2 quarters · filed 2025-05-07 | 76.44M shares derived: average of 3 quarters · filed 2025-05-07 | 75.68M shares derived: average of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | 74.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | 74.17M shares derived: average of 2 quarters · filed 2025-03-10 | 73.91M shares derived: average of 3 quarters · filed 2025-03-10 | 73.79M shares 10-K · filed 2025-03-10 |
| 2023-09-30 | 73.92M shares 10-Q · filed 2024-11-06 | 73.66M shares derived: average of 2 quarters · filed 2024-11-06 | 73.58M shares 10-Q · filed 2024-11-06 | 68.95M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | 73.40M shares 10-Q · filed 2024-08-08 | 73.25M shares 10-Q · filed 2024-08-08 | 67.29M shares derived: average of 3 quarters · filed 2024-08-08 | 60.81M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 73.10M shares 10-Q · filed 2024-05-14 | 64.23M shares derived: average of 2 quarters · filed 2024-05-14 | 56.61M shares derived: average of 3 quarters · filed 2024-05-14 | 52.78M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 55.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | 48.36M shares derived: average of 2 quarters · filed 2024-03-18 | 46.01M shares derived: average of 3 quarters · filed 2024-03-18 | 44.82M shares 10-K · filed 2024-03-18 |
| 2022-09-30 | 41.36M shares 10-Q · filed 2023-11-08 | 41.33M shares derived: average of 2 quarters · filed 2023-11-08 | 41.31M shares 10-Q · filed 2023-11-08 | 41.36M shares derived: average of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | 41.30M shares 10-Q · filed 2023-08-09 | 41.29M shares 10-Q · filed 2023-08-09 | 41.36M shares derived: average of 3 quarters · filed 2023-08-09 | 37.74M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 41.27M shares 10-Q · filed 2023-05-10 | 41.39M shares derived: average of 2 quarters · filed 2023-05-10 | 36.56M shares derived: average of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | 41.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | 34.20M shares derived: average of 2 quarters · filed 2023-03-08 | 17.73M shares 10-K · filed 2023-03-08 | |
| 2021-09-30 | 26.90M shares 10-Q · filed 2022-11-10 | 9.81M shares 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |